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Abstract
Background: Body size, nutrition and socioeconomic position (SEP) in early life have been associated with a range
of later life health outcomes. Epigenetic regulation is one mechanism through which these early life factors may
impact later life health. The aim of this review protocol is to outline procedures to document the influence of body
size, nutrition and SEP in early life on the epigenome.
Methods: MEDLINE, Embase and BIOSIS will be systematically searched using pre-defined keywords. Additional
studies will be identified through manual searching of reference lists. Two independent researchers will assess the
eligibility and quality of each study, with disagreements being resolved through discussion or a third reviewer.
Studies will be included if they have epigenetic markers measured either at the same time as, or after, the early life
exposure and, have a measure of body size, nutrition or SEP in early life (up to 12 years), are in the English
language and are from a sample of community-dwelling participants.
Discussion: This protocol will be used to collate the evidence for the effect of early life factors on the epigenome.
Findings will form a component of a wider research study examining epigenetic responses to exposures in early life
and over the life course and its impact on healthy ageing using data from population-based cohort studies.
Systematic review registration: PROSPERO CRD42016050193
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Background
The extensive growth and development that occurs in
utero and childhood marks a sensitive period during
which external factors can elicit biological changes which
programme an individual’s ability to maintain health or in-
crease risk of later life disease [1–3]. Body size, nutrition
and socioeconomic position (SEP) at birth and during
childhood are commonly studied characteristics which
have been strongly linked with later life health [4–9].
There are a variety of mechanisms through which these
early life factors may impact later life health [2, 4, 7, 10].
Epigenetic regulation is one such mechanism [2, 11].
Epigenetics refers to alterations in gene expression.
Epigenetic modifications do not alter the sequence of
DNA, but can regulate how that DNA is expressed and
ultimately, how the gene functions. Epigenetic modifi-
cations include histone modifications and DNA methy-
lation amongst others [12]. These malleable epigenetic
signals are essential for development and cell prolifera-
tion but can also occur in response to environmental
stimuli [13]. Evidence from animal studies and a limited
number of human studies suggests that early life expo-
sures can modify several epigenetic signatures in a
multitude of genes [11, 14].
Understanding which early life exposures evoke changes
in the epigenome, and identifying the genomic regions in
which these changes are occurring will support efforts to
maintain health and prevent disease in later life. Further-
more, since epigenetic changes are potentially modifiable,
a greater understanding of the specific changes induced by
early life factors can elucidate potential targets for inter-
vention strategies.* Correspondence: Jane.maddock@ucl.ac.uk
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Since this is a relatively new area of research, most evi-
dence examining the epigenetic effect of early life factors
have come from animal and exploratory studies incorporat-
ing a variety of early life exposures and applying different
analytical methods. Although there has been some review of
the role of early life factors on the epigenome in humans
[15], to the best of our knowledge, there has been no sys-
tematic review of the existing literature examining body size,
nutrition and social exposures in relation to epigenetic sig-
nals. This review will collate human studies examining the
impact of these early life exposures on epigenetics measured
at the same time or any age subsequent to the exposure.
Aim
The overall aim of the review is to examine the epigenetic
effect of the following factors:
i. Body size and growth in early life
ii. Nutrition during pregnancy and early life
iii. Markers of socioeconomic position in early life
Methods/design protocol registration
This study protocol is registered with the PROSPERO
database (registration number: CRD42016050193) and
has been reported using the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses Protocols
(PRISMA-P) checklist, included as Additional file 1.
Key terms
For the purposes of this review, early life is defined as
the period including prenatal, infancy, early and middle
childhood, up to 12 years to capture the pre-adolescence
period. Full definitions of each of each key variable used
in the review can be found in Table 1.
Eligibility criteria
Papers will be included if they meet the following criteria:
 Original studies published in peer-reviewed journals
 Epigenetic markers measured either at the same
time or any age subsequent to the early life exposure
(i.e. epigenetics can be measures in infancy,
childhood, adolescence or adulthood)
 Current, prospective report or retrospective recall of
indicators of body size (see Table 1)
 Current, prospective report or retrospective recall of
nutrition and/or diet (see Table 1)
 Current, prospective report or retrospective recall
SEP (see Table 1)
 English language
 Non-clinical samples
We will not include:
 Studies not meeting inclusion criteria
 Reviews
 Studies based on animals
 Studies only assessing the effect of adulthood
exposures on epigenetic markers
 Studies assessing the effect of epigenetic markers
before early life exposures
 Samples with a specific clinical condition
Search strategy
Using OvidSP as the database interface, a joint electronic
search on MEDLINE and Embase will be conducted. The
BIOSIS database will be searched using ISI Web of Sci-
ence. The search will use free-text search terms (Table 2)
with truncations to allow for different spellings, proximity
operators (‘adj’ in OvidSP, ‘NEAR’ in ISI Web of Science)
and joined using Boolean logic (“AND”, “OR”). The refer-
ence lists’ of relevant reviews, all included papers and their
ISI citation index (via Web of Science) will be searched for
studies meeting inclusion criteria. Eligible studies identified
will be combined with the electronic search results.
Study selection
Results of the searches will be merged and stored in the
reference manager, EndNote. All duplicate citations will
be removed. All abstracts will be screened for eligibility
by two independent researchers (from JM, WW and
RH). The full text of all potentially eligible papers will
then also be double screened and reasons for their
Table 1 Definitions of key variables included in review
Term Description
Epigenetics Any recognised indicator of DNA methylation or histone modification, measured in any tissue
Body size Any measure of body size including: weight, height, BMI, head circumference and growth
(or change) in any of these measurements at birth and in early life
Nutrition Any measure of maternal nutrition, supplement use and/or diet during pregnancy, breastfeeding/
formula, weaning practices and nutrition/diet of the child in early life measured using dietary
questionnaires and/or objectively measured nutritional biomarkers
Socioeconomic position (SEP) Any recognised indicator of SEP within society, including occupation, education, income, occupational
or social class, poverty and household overcrowding, as defined in reference [16], measured during
early life
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exclusion will be documented. Disagreements about the
paper’s eligibility will be resolved through discussion and
if necessary, a third reviewer.
Data extraction
Each reviewer will extract the relevant information using
the data extraction form (Additional file 2).The following
information will be extracted from selected papers:
citation details, study details including design, country/
region and sample size; participant details including age
and sex; and exposure and outcome details, including
details on methods used. A free-text box for recording
main findings will be used because of the expected
heterogeneous methods that will have been used.
Quality assessment
Various tools for assessing the quality of observational
studies such as the Downs and Black checklist [16] and
Newcastle-Ottawa Scale [17] are available. However,
these are not suitable for assessing the quality of epi-
genetic studies. The following aspects of the paper
which may relate to the quality of each study will be
extracted and discussed; study design, methods used to
measure epigenetics, statistical analysis including
adjustment of relevant confounders, recall bias, i.e. pro-
spective or retrospective measures of early life factors
and generalisability [18].
Synthesis
Descriptive tables will be used to outline the included
studies in the systematic review. Results will be grouped
under the following thematic groups: (1) body size in
early life; (2) nutrition in early life; 3) SEP in early life. If
there is more than one exposure assessed in an individ-
ual study, they will be discussed separately where prac-
tical. If feasible, the effects of similar epigenetic analyses
methods, e.g. epigenome-wide association studies/locus-
specific studies and the age at which epigenetic markers
were identified will also be grouped within each theme.
Due to the expected diversity in eligible studies, in
terms of methods used, a meta-analysis will not be con-
ducted [18]. Therefore, a narrative synthesis will be
undertaken. The structure of the narrative synthesis will
be based on guidance from Economic and Social
Research Council Methods Programme [19]. This will
involve preliminary synthesis, exploring relationships
between and within studies, with particular focus on
sources of heterogeneity in study design and characteris-
tics between studies, and assessing the robustness of the
synthesis, i.e. assessing the strength of the evidence
given the methodological quality and generalisability of
included papers [18, 19].
Table 2 Search terms
Epigenetics
1 (epigen* )
2 (EWAS)
3 (Methylation)
4 (DNA adj5 methyl*)
5 (differential adj1 methylation)
6 (global adj1 methylation)
7 (DNA adj5 hypermethyl*)
8 (DNA adj5 hypomethyl*)
9 (gene* adj5 methyl*)
10 Gene Expression Regulation
11 (methyl* adj5 region)
12 (histone adj1 modif*)
13 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12
Body size/ growth
14 ((premature or pre-mature or preterm or pre-term) adj2 (birth or infant*
or child* or neonat*))
15 (gestation* adj2 age)
16 (weight or body-size or bmi or height or length or head-circumference)
17 ((grow*) adj3 (fet* or neonat* or prenatal* or pre-natal* or intrauterine or in-
utero or postnatal or post-natal or birth* or infant* or child* or
early-life or earlylife))
18 (fet* or neonat* or prenatal* or pre-natal* or intrauterine or in-utero
or postnatal or post-natal or birth* or infant* or child* or early-life)
19 16 OR 17
20 18 AND 19
21 14 OR 15 OR 20
Nutrition
22 (nutrition adj3 (maternal or mother* or pregn* or fet* or neonat* or
prenatal* or pre-natal* or intrauterine or in-utero))
23 ((nutrition or diet or wean*) adj3 (postnatal or post-natal or infant* or
child* or early-life))
24 (breastfe* or breast-fe*)
25 (formula adj3 (infant* or child* or early-life))
26 22 OR 23 OR 24 OR 25
Socioeconomic position
27 ((occupation* or education*) adj3 (father* or mother* or parent*))
28 ((income or manual) adj3 (father* or mother* or parent*))
29 ((social class or social status) adj3 (father* or mother* or parent* or
child* or early-life))
30 ((socioeconomic or socio-economic) adj3 (father* or mother* or parent*
or child* or early-life))
31 ((deprivation or poverty) adj3 (child* or early-life))
32 ((overcrowding) adj3 (child* or early-life))
33 27 OR 28 OR 29 OR 30 OR 31 OR 32
Combining results
34 21 OR 26 OR 33
35 13 AND 33
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Reporting
The findings of this systematic review will be reported in
accordance with the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses Protocols (PRISMA-P)
guidelines [20].
Discussion
This study will systematically review the literature exam-
ining the effect of body size and growth, nutrition and
socioeconomic position in early life on the epigenome.
The relationship between different early life exposures
and epigenetics as well as other sources of between-
study heterogeneity will be explored. The strengths and
limitations, and therefore potential for bias, of individual
studies will be considered. Since this is a relatively new
field, we anticipate that there will be a small number of
studies and considerable between-study heterogeneity in
terms of study design and characteristics. In addition to
collating existing evidence of the effects of early life on
the epigenome, this review will form a significant com-
ponent of a wider research study examining epigenetic
responses to exposures in early life and over the life
course and its impact on healthy ageing.
Additional files
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extracting data from selected papers. (DOCX 25 kb)
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